Igm Biosciences Stock Probability of Future Stock Price Finishing Under 8.89
| IGMS Stock | USD 8.89 0.88 9.01% |
IGM |
IGM Biosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of IGM Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for IGM Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| IGM Biosciences had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 2.13 M. Net Loss for the year was (246.42 M) with profit before overhead, payroll, taxes, and interest of 1.07 M. | |
| IGM Biosciences currently holds about 469.14 M in cash with (192.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.95, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| IGM Biosciences has a poor financial position based on the latest SEC disclosures | |
| Roughly 64.0% of the company shares are owned by institutional investors |
IGM Biosciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of IGM Stock often depends not only on the future outlook of the current and potential IGM Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. IGM Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 52.3 M | |
| Cash And Short Term Investments | 337.7 M |
IGM Biosciences Technical Analysis
IGM Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. IGM Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of IGM Biosciences. In general, you should focus on analyzing IGM Stock price patterns and their correlations with different microeconomic environments and drivers.
IGM Biosciences Predictive Forecast Models
IGM Biosciences' time-series forecasting models is one of many IGM Biosciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary IGM Biosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about IGM Biosciences
Checking the ongoing alerts about IGM Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for IGM Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| IGM Biosciences had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 2.13 M. Net Loss for the year was (246.42 M) with profit before overhead, payroll, taxes, and interest of 1.07 M. | |
| IGM Biosciences currently holds about 469.14 M in cash with (192.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.95, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| IGM Biosciences has a poor financial position based on the latest SEC disclosures | |
| Roughly 64.0% of the company shares are owned by institutional investors |
Additional Tools for IGM Stock Analysis
When running IGM Biosciences' price analysis, check to measure IGM Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IGM Biosciences is operating at the current time. Most of IGM Biosciences' value examination focuses on studying past and present price action to predict the probability of IGM Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IGM Biosciences' price. Additionally, you may evaluate how the addition of IGM Biosciences to your portfolios can decrease your overall portfolio volatility.